BC Cancer - Victoria

2410 Lee Avenue
Victoria, BC, V8R 6V5

Clinical Trial Unit Manager
Philip Pollock
250-519-5597
philip.pollock@bccancer.bc.ca

Brain & Central Nervous System Cancer

DB102-01: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1

Cancer Type
Brain & Central Nervous System Cancer
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Abbotsford
Open Recruiting Date
View on ClinicalTrials.gov
Back to top